MA21446A1 - Nouveaux derives de pyridazinamine et procede de destruction de virus ou de prevention contre leur developpement chez les animaux a sang chaud, composition antivirale en comportant application ainsi que leur procede de preparation. - Google Patents

Nouveaux derives de pyridazinamine et procede de destruction de virus ou de prevention contre leur developpement chez les animaux a sang chaud, composition antivirale en comportant application ainsi que leur procede de preparation.

Info

Publication number
MA21446A1
MA21446A1 MA21689A MA21689A MA21446A1 MA 21446 A1 MA21446 A1 MA 21446A1 MA 21689 A MA21689 A MA 21689A MA 21689 A MA21689 A MA 21689A MA 21446 A1 MA21446 A1 MA 21446A1
Authority
MA
Morocco
Prior art keywords
novel
6alkyl
development
preparation
well
Prior art date
Application number
MA21689A
Other languages
English (en)
Inventor
Jozef Maria Van Der Aa Marcel
Gerebernus Maria Luyckx Marcel
Arthur Jules Grauwels Gilbert
Antoine Stokbroeks Raymond
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA21446A1 publication Critical patent/MA21446A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MA21689A 1987-11-23 1988-11-22 Nouveaux derives de pyridazinamine et procede de destruction de virus ou de prevention contre leur developpement chez les animaux a sang chaud, composition antivirale en comportant application ainsi que leur procede de preparation. MA21446A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12453087A 1987-11-23 1987-11-23

Publications (1)

Publication Number Publication Date
MA21446A1 true MA21446A1 (fr) 1989-07-01

Family

ID=22415413

Family Applications (1)

Application Number Title Priority Date Filing Date
MA21689A MA21446A1 (fr) 1987-11-23 1988-11-22 Nouveaux derives de pyridazinamine et procede de destruction de virus ou de prevention contre leur developpement chez les animaux a sang chaud, composition antivirale en comportant application ainsi que leur procede de preparation.

Country Status (26)

Country Link
EP (1) EP0320032B1 (fr)
JP (1) JPH0629255B2 (fr)
KR (1) KR0125280B1 (fr)
CN (1) CN1021328C (fr)
AT (1) ATE117296T1 (fr)
AU (1) AU611504B2 (fr)
BG (1) BG60676B1 (fr)
CA (1) CA1327573C (fr)
DE (1) DE3852816T2 (fr)
DK (1) DK651288A (fr)
ES (1) ES2070126T3 (fr)
FI (1) FI92584C (fr)
GR (1) GR3015816T3 (fr)
HU (1) HU200762B (fr)
IE (1) IE65768B1 (fr)
IL (1) IL88429A (fr)
JO (1) JO1552B1 (fr)
MA (1) MA21446A1 (fr)
MY (1) MY104343A (fr)
NO (1) NO171980C (fr)
NZ (1) NZ226920A (fr)
PH (1) PH26670A (fr)
PT (1) PT89047B (fr)
SU (1) SU1724013A3 (fr)
TN (1) TNSN88128A1 (fr)
ZA (1) ZA888744B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
JO1645B1 (en) * 1989-12-26 1991-11-27 شركة جانسين فارماسوتيكا ان. في Pyridazine compounds are antibacterial viruses
US5169855A (en) * 1990-03-28 1992-12-08 Du Pont Merck Pharmaceutical Company Piperidine ether derivatives as psychotropic drugs or plant fungicides
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
FR2668151A1 (fr) * 1990-10-23 1992-04-24 Rhone Poulenc Agrochimie Composes a groupe triazolopyridazine leurs preparations et compositions herbicides les contenant.
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5242924A (en) * 1992-07-02 1993-09-07 Sterling Winthrop Inc. Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents
CA2099630A1 (fr) * 1992-07-02 1994-01-03 Guy Dominic Diana Utilisation de phenoxyalkyl-piperidinylpyridazines heterocycliques comme agents antiviraux
US5364865A (en) * 1992-12-30 1994-11-15 Sterling Winthrop Inc. Phenoxy- and phenoxyalkyl-piperidines as antiviral agents
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
EP0690847A1 (fr) * 1993-03-29 1996-01-10 Zeneca Limited Composes heterocycliques en tant qu'inhibiteurs de l'agregation plaquettaire
AU692438B2 (en) * 1993-03-29 1998-06-11 Astrazeneca Ab Heterocyclic derivatives as platelet aggregation inhibitors
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
EE04588B1 (et) * 1997-10-27 2006-02-15 Neurosearch A/S Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
AU755361B2 (en) 1998-02-19 2002-12-12 Eisai R&D Management Co., Ltd. Phthalazine derivatives and remedies for erectile dysfunction
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6316500B1 (en) * 1999-01-05 2001-11-13 Isp Investments Inc. Aliphatically unsaturated hydroxy benzoates and preservative compositions thereof
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
AU2002331621B2 (en) 2001-08-15 2008-06-05 Icos Corporation 2H-phthalazin-1-ones and methods for use thereof
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
JP4544999B2 (ja) * 2002-11-25 2010-09-15 持田製薬株式会社 4−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
PL1648874T3 (pl) 2003-07-30 2012-04-30 Xenon Pharmaceuticals Inc Pochodne piperazyny i ich zastosowanie jako środków leczniczych
US7759348B2 (en) 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
US7754711B2 (en) * 2003-07-30 2010-07-13 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
CA2533897A1 (fr) * 2003-07-30 2005-02-10 Xenon Pharmaceuticals Inc. Derives de pyridazine et utilisation de ceux-ci en tant qu'agents therapeutiques
SG154433A1 (en) * 2004-06-30 2009-08-28 Janssen Pharmaceutica Nv Phthalazine derivatives as parp inhibitors
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
CN101084211A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
CA2618646A1 (fr) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Derives aminothiazole utilises en tant qu'inhibiteurs de la stearoyle-coa desaturase humaine
MX2007016508A (es) * 2005-06-30 2008-03-04 Prosidion Ltd Agonistas del receptor acoplado a la proteina g.
CN1887875B (zh) * 2005-06-30 2011-04-06 深圳市东阳光实业发展有限公司 哒嗪胺衍生物及其用于制备小rna病毒抑制剂的用途
MX2007015675A (es) 2005-07-04 2008-02-20 Novo Nordisk As Antagonistas del receptor de histamina h3.
EP2402324A1 (fr) 2006-05-29 2012-01-04 High Point Pharmaceuticals, LLC Benzodioxolylcyclopropylpipérazinylpyridazines
EP2014656A3 (fr) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC Nouveaux antagonistes d'hétéocycliques h3
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
CN102344416B (zh) 2010-08-02 2015-09-16 中国人民解放军军事医学科学院毒物药物研究所 哒嗪衍生物及其作为抗小rna病毒感染药物的用途
CN102485717B (zh) * 2010-12-06 2015-12-02 中国人民解放军军事医学科学院毒物药物研究所 噻唑胺衍生物及其作为抗小rna病毒感染药物的用途
TW201329025A (zh) 2011-11-01 2013-07-16 Astex Therapeutics Ltd 醫藥化合物
EP3749697A4 (fr) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. Résine de chromatographie ayant un ligand mode mixte échange anionique/hydrophobe
CN118047485B (zh) * 2024-04-08 2024-06-25 西安文理学院 一种污水治理的复合微生物菌剂及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8802151A1 (es) * 1985-07-31 1988-04-01 Janssen Pharmaceutica Nv Un procedimiento para la preparacion de nuevos piridazinaminas.

Also Published As

Publication number Publication date
ATE117296T1 (de) 1995-02-15
DE3852816T2 (de) 1995-06-08
NO171980C (no) 1993-05-26
TNSN88128A1 (fr) 1990-07-10
IE883486L (en) 1989-05-23
BG86132A (bg) 1993-12-24
IE65768B1 (en) 1995-11-15
PT89047A (pt) 1988-12-01
JPH01207278A (ja) 1989-08-21
NO171980B (no) 1993-02-15
AU611504B2 (en) 1991-06-13
BG60676B1 (bg) 1995-12-29
DK651288D0 (da) 1988-11-22
IL88429A (en) 1993-05-13
NO885190D0 (no) 1988-11-22
NZ226920A (en) 1990-06-26
KR890008126A (ko) 1989-07-08
CN1021328C (zh) 1993-06-23
JPH0629255B2 (ja) 1994-04-20
GR3015816T3 (en) 1995-07-31
DE3852816D1 (de) 1995-03-02
ES2070126T3 (es) 1995-06-01
MY104343A (en) 1994-03-31
FI885409A0 (fi) 1988-11-22
EP0320032A1 (fr) 1989-06-14
HUT48617A (en) 1989-06-28
KR0125280B1 (ko) 1997-12-05
CA1327573C (fr) 1994-03-08
ZA888744B (en) 1990-07-25
SU1724013A3 (ru) 1992-03-30
AU2575188A (en) 1989-05-25
CN1033274A (zh) 1989-06-07
EP0320032B1 (fr) 1995-01-18
HU200762B (en) 1990-08-28
IL88429A0 (en) 1989-06-30
FI885409A7 (fi) 1989-05-24
DK651288A (da) 1989-05-24
JO1552B1 (en) 1989-12-16
FI92584C (fi) 1994-12-12
NO885190L (no) 1989-05-24
PT89047B (pt) 1993-03-31
FI92584B (fi) 1994-08-31
PH26670A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
MA21446A1 (fr) Nouveaux derives de pyridazinamine et procede de destruction de virus ou de prevention contre leur developpement chez les animaux a sang chaud, composition antivirale en comportant application ainsi que leur procede de preparation.
TNSN90032A1 (fr) Derives de n-(3-hydroxy-4-piperidinyl) (dihydro-benzofuranne, dihydro-2h-benzopyranne ou dihydro-benzodioxin) carboxamide, et leur procede de preparation
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2&#39;-iminobisetanol.
DE3481841D1 (de) Bicyclische kondensierte n-(4-piperidinyl)-2-imidazolamin-derivate.
PT88577A (pt) Process for the manufacture of novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE68922537D1 (de) Antipsychotische 3-Piperazinylbenzazolderivate.
NO179553C (no) Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.